Our work proposed a novel mechanism of LRPPRC in mediating m6A modification of PD-L1 mRNA during HCC, which might further the present molecular understanding of immunosuppression and offer more effective immunotherapeutic regimens. This evidence concerns the gene LRPPRC and hepatocellular carcinoma.